QUOTE

Thursday, February 26, 2004 Posted: 0406 GMT (12:06 PM HKT) WASHINGTON (CNN) -- A South Carolina psychiatrist said Wednesday he will immediately start recruiting patients after winning approval to conduct the first study testing MDMA -- better known as ecstasy -- as a therapeutic tool. Dr. Michael Mithoefer plans to conduct psychotherapy sessions with 20 women who suffer from post-traumatic stress disorder due to sexual assaults or other violence, and who haven't been helped by other treatment. Twelve of the women will receive MDMA prior to the sessions while eight will be given a placebo. The Food and Drug Administration approved Mithoefer's protocol in 2001, but it took another two years to find an institutional review board willing to sanction the study, which is a required step when dealing with human research subjects. Mithoefer's research required approval from the Drug Enforcement Administration because MDMA is a Schedule I drug. It's grouped with drugs like heroin, ###### and LSD, all considered to have no medical use. Bill Grant, a spokesman for the DEA, said the final approval came Tuesday night. Mithoefer says he works with post-traumatic stress disorder patients all the time and he's excited about the possibility of finding a better treatment for the hundreds of thousands of Americans who suffer from the sometimes debilitating disorder

 

QUOTE

Thursday, February 26, 2004 Posted: 0406 GMT (12:06 PM HKT) WASHINGTON (CNN) -- A South Carolina psychiatrist said Wednesday he will immediately start recruiting patients after winning approval to conduct the first study testing MDMA -- better known as ecstasy -- as a therapeutic tool. Dr. Michael Mithoefer plans to conduct psychotherapy sessions with 20 women who suffer from post-traumatic stress disorder due to sexual assaults or other violence, and who haven't been helped by other treatment. Twelve of the women will receive MDMA prior to the sessions while eight will be given a placebo. The Food and Drug Administration approved Mithoefer's protocol in 2001, but it took another two years to find an institutional review board willing to sanction the study, which is a required step when dealing with human research subjects. Mithoefer's research required approval from the Drug Enforcement Administration because MDMA is a Schedule I drug. It's grouped with drugs like heroin, ###### and LSD, all considered to have no medical use. Bill Grant, a spokesman for the DEA, said the final approval came Tuesday night. Mithoefer says he works with post-traumatic stress disorder patients all the time and he's excited about the possibility of finding a better treatment for the hundreds of thousands of Americans who suffer from the sometimes debilitating disorder.

 

Taken from: http://edition.cnn.com/2004/HEALTH/02/25/e...tudy/index.html

 

Thoughts on this anyone?? the ### is c.o.c.a.i.n.e!!

It was used lost in the 60s and 70s iirc as a therapeutic tool allowing patients to be more open and honest with their psychiatrists and to explore their feelings more deeply.

 

It was this reason that it was in the end banned. The psychiatrists that were researching it couldn't ignore its use as it was so important but they knew that as soon as the research was published the drug would get banned as it has an hallucinogenic affect.

 

I think it's a good idea to reopen the research, if it helps people then that's for the good. I think the research sample is pretty small though.

well I agree, small or huge, any research is good IMO!!

look forward to some good unbiased scientific results from this then...

Ok i actually have a friend in london, whom has just finished medical testing for e, and actually got payed for it.